Transcription factor NFE2L2/NRF2 is a regulator of macroautophagy genes

Autophagy

Volumn 12, Issue 10, 2016, Pages 1902-1916

  Pajares, Marta ^a,b   Jiménez Moreno, Natalia ^a,b,c   García Yagüe, Ángel J ^a,b   Escoll, Maribel ^a,b   de Ceballos, María L ^b,d   Van Leuven, Fred ^e   Rábano, Alberto ^f   Yamamoto, Masayuki ^g   Rojo, Ana I ^a,b   Cuadrado, Antonio ^a,b  

^a AUTONOMOUS UNIVERSITY OF MADRID   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c UNIVERSITY OF BRISTOL   (United Kingdom)

^d INSTITUTO CAJAL   (Spain)

^e UNIVERSITY OF LEUVEN   (Belgium)

^f Instituto de Salud Carlos III   (Spain)

^g TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Alzheimer disease; amyloid precursor protein; neurodegenerative diseases; neuroprotection; oxidative stress; proteostasis; Tau

Indexed keywords

BACH1 PROTEIN; HYDROGEN PEROXIDE; PROTEIN; SULFORAPHANE; TRANSCRIPTION FACTOR MAFK; TRANSCRIPTION FACTOR NRF2; UNCLASSIFIED DRUG; AMYLOID BETA PROTEIN; MICROTUBULE ASSOCIATED PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIOXIDANT RESPONSIVE ELEMENT; ARTICLE; AUTOPHAGY; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; EMBRYO; FIBROBLAST; GENE EXPRESSION; HUMAN; HUMAN CELL; MACROAUTOPHAGY; MOUSE; NONHUMAN; PROTEIN AGGREGATION; QUANTITATIVE ANALYSIS; REGULATOR GENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; AGED; ALZHEIMER DISEASE; ANIMAL; DEFICIENCY; DISEASE MODEL; GENE EXPRESSION REGULATION; GENETICS; HEK293 CELL LINE; METABOLISM; MIDDLE AGED; NERVE CELL; PATHOLOGY; PROMOTER REGION; TRANSGENIC MOUSE; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; ANIMALS; ANTIOXIDANT RESPONSE ELEMENTS; AUTOPHAGY; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION; HEK293 CELLS; HUMANS; MICE, TRANSGENIC; MICROTUBULE-ASSOCIATED PROTEINS; MIDDLE AGED; NEURONS; NF-E2-RELATED FACTOR 2; PROMOTER REGIONS, GENETIC;

EID: 84982256774     PISSN: 15548627     EISSN: 15548635     Source Type: Journal    
DOI: 10.1080/15548627.2016.1208889     Document Type: Article

References (76)

1. D.C.Rubinsztein, G.Marino, G.Kroemer. Autophagy and aging. Cell 2011; 146:682-95; PMID:21884931; http://dx.doi.org/10.1016/j.cell.2011.07.030
2. A.Ciechanover, Y.T.Kwon. Degradation of misfolded proteins in neurodegenerative diseases:therapeutic targets and strategies. Exp Mol Med 2015; 47:e147; PMID:25766616; http://dx.doi.org/10.1038/emm.2014.117
3. D.J.Klionsky, S.D.Emr. Autophagy as a regulated pathway of cellular degradation. Science 2000; 290:1717-21; PMID:11099404; http://dx.doi.org/10.1126/science.290.5497.1717
4. J.Kim, M.Kundu, B.Viollet, K.L.Guan. AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1. Nat Cell Biol 2011; 13:132-41; PMID:21258367; http://dx.doi.org/10.1038/ncb2152
5. C.Settembre, C.Di Malta, V.A.Polito, M.Garcia Arencibia, F.Vetrini, S.Erdin, S.U.Erdin, T.Huynh, D.Medina, P.Colella, et al. TFEB links autophagy to lysosomal biogenesis. Science 2011; 332:1429-33; PMID:21617040; http://dx.doi.org/10.1126/science.1204592
6. S.Seok, T.Fu, S.E.Choi, Y.Li, R.Zhu, S.Kumar, X.Sun, G.Yoon, Y.Kang, W.Zhong, et al. Transcriptional regulation of autophagy by an FXR-CREB axis. Nature 2014; 516:108-11; PMID:25383523
7. M.R.Warr, M.Binnewies, J.Flach, D.Reynaud, T.Garg, R.Malhotra, J.Debnath, E.Passegué. FOXO3A directs a protective autophagy program in haematopoietic stem cells. Nature 2013; 494:323-7; PMID:23389440; http://dx.doi.org/10.1038/nature11895
8. R.M.Perera, S.Stoykova, B.N.Nicolay, K.N.Ross, J.Fitamant, M.Boukhali, J.Lengrand, V.Deshpande, M.K.Selig, C.R.Ferrone, et al. Transcriptional control of autophagy-lysosome function drives pancreatic cancer metabolism. Nature 2015; 524:361-5; PMID:26168401; http://dx.doi.org/10.1038/nature14587
9. S.Chauhan, J.G.Goodwin, S.Chauhan, G.Manyam, J.Wang, A.M.Kamat, D.D.Boyd. ZKSCAN3 is a master transcriptional repressor of autophagy. Mol Cell 2013; 50:16-28; PMID:23434374; http://dx.doi.org/10.1016/j.molcel.2013.01.024
10. C.J.Bowman, D.E.Ayer, B.D.Dynlacht. Foxk proteins repress the initiation of starvation-induced atrophy and autophagy programs. Nat Cell Biol 2014; 16:1202-14; PMID:25402684; http://dx.doi.org/10.1038/ncb3062
11. L.R.Lapierre, C.Kumsta, M.Sandri, A.Ballabio, M.Hansen. Transcriptional and epigenetic regulation of autophagy in aging. Autophagy 2015; 11:867-80; PMID:25836756; http://dx.doi.org/10.1080/15548627.2015.1034410
12. G.Milan, V.Romanello, F.Pescatore, A.Armani, J.H.Paik, L.Frasson, A.Seydel, J.Zhao, R.Abraham, A.L.Goldberg, et al. Regulation of autophagy and the ubiquitin-proteasome system by the FoxO transcriptional network during muscle atrophy. Nat Commun 2015; 6:6670; PMID:25858807; http://dx.doi.org/10.1038/ncomms7670
13. J.D.Hayes, A.T.Dinkova-Kostova. The Nrf2 regulatory network provides an interface between redox and intermediary metabolism. Trends Biochem Sci 2014; 39:199-218; PMID:24647116; http://dx.doi.org/10.1016/j.tibs.2014.02.002
14. T.Suzuki, M.Yamamoto. FRBM Special issue “Nrf2 regulated Redox Signaling and Metabolism in Physiology and Medicine” Molecular basis of the Keap1-Nrf2 system. Free Radic Biol Med 2015
15. T.Jiang, B.Harder, M.R.Vega, P.K.Wong, E.Chapman, D.D.Zhang. p62 links autophagy and Nrf2 signaling. Free Radic Biol Med 2015; 88(Pt B):199-204
16. Y.Ichimura, S.Waguri, Y.S.Sou, S.Kageyama, J.Hasegawa, R.Ishimura, T.Saito, Y.Yang, T.Kouno, T.Fukutomi, et al. Phosphorylation of p62 activates the Keap1-Nrf2 pathway during selective autophagy. Mol Cell 2013; 51:618-31; PMID:24011591; http://dx.doi.org/10.1016/j.molcel.2013.08.003
17. A.Jain, T.Lamark, E.Sjottem, K.B.Larsen, J.A.Awuh, A.Overvatn, M.McMahon, J.D.Hayes, T.Johansen. p62/SQSTM1 is a target gene for transcription factor NRF2 and creates a positive feedback loop by inducing antioxidant response element-driven gene transcription. J Biol Chem 2010; 285:22576-91; PMID:20452972; http://dx.doi.org/10.1074/jbc.M110.118976
18. C.Jo, S.Gundemir, S.Pritchard, Y.N.Jin, I.Rahman, G.V.Johnson. Nrf2 reduces levels of phosphorylated tau protein by inducing autophagy adaptor protein NDP52. Nat Commun 2014; 5:3496; PMID:24667209
19. T.Hara, K.Nakamura, M.Matsui, A.Yamamoto, Y.Nakahara, R.Suzuki-Migishima, M.Yokoyama, K.Mishima, I.Saito, H.Okano, et al. Suppression of basal autophagy in neural cells causes neurodegenerative disease in mice. Nature 2006; 441:885-9; PMID:16625204; http://dx.doi.org/10.1038/nature04724
20. K.Inoue, J.Rispoli, H.Kaphzan, E.Klann, E.I.Chen, J.Kim, M.Komatsu, A.Abeliovich. Macroautophagy deficiency mediates age-dependent neurodegeneration through a phospho-tau pathway. Mol Neurodegener 2012; 7:48; PMID:22998728; http://dx.doi.org/10.1186/1750-1326-7-48
21. M.Komatsu, S.Waguri, T.Chiba, S.Murata, J.Iwata, I.Tanida, T.Ueno, M.Koike, Y.Uchiyama, E.Kominami, et al. Loss of autophagy in the central nervous system causes neurodegeneration in mice. Nature 2006; 441:880-4; PMID:16625205; http://dx.doi.org/10.1038/nature04723
22. T.Jaworski, I.Dewachter, C.M.Seymour, P.Borghgraef, H.Devijver, S.Kugler, F.Van Leuven. Alzheimer's disease:old problem, new views from transgenic and viral models. Biochimica et biophysica acta 2010; 1802:808-18; PMID:20332023; http://dx.doi.org/10.1016/j.bbadis.2010.03.005
23. R.A.Nixon. Autophagy, amyloidogenesis and Alzheimer disease. J Cell Sci 2007; 120:4081-91; PMID:18032783; http://dx.doi.org/10.1242/jcs.019265
24. B.Boland, A.Kumar, S.Lee, F.M.Platt, J.Wegiel, W.H.Yu, R.A.Nixon. Autophagy induction and autophagosome clearance in neurons:relationship to autophagic pathology in Alzheimer's disease. J Neurosci 2008; 28:6926-37; PMID:18596167; http://dx.doi.org/10.1523/JNEUROSCI.0800-08.2008
25. http://www.webcitation.org/query?url=https%3A%2F%2Fgenome.ucsc.edu%2F&date=2015-07-29
26. http://www.webcitation.org/query?url=http%3A%2F%2Fjaspar.genereg.net%2F&date=2015-07-29
27. M.McMahon, K.Itoh, M.Yamamoto, J.D.Hayes. Keap1-dependent proteasomal degradation of transcription factor Nrf2 contributes to the negative regulation of antioxidant response element-driven gene expression. J Biol Chem 2003; 278:21592-600; PMID:12682069; http://dx.doi.org/10.1074/jbc.M300931200
28. H.R.Potteti, N.M.Reddy, T.K.Hei, D.V.Kalvakolanu, S.P.Reddy. The NRF2 activation and antioxidative response are not impaired overall during hyperoxia-induced lung epithelial cell death. Oxid Med Cell Longev 2013; 2013:798401; PMID:23738042; http://dx.doi.org/10.1155/2013/798401
29. A.Hac, A.Domachowska, M.Narajczyk, K.Cyske, A.Pawlik, A.Herman-Antosiewicz. S6K1 controls autophagosome maturation in autophagy induced by sulforaphane or serum deprivation. Euro J Cell Biol 2015; 94(10):470-81; PMID:26054233
30. J.H.Lee, J.K.Jeong, S.Y.Park. Sulforaphane-induced autophagy flux prevents prion protein-mediated neurotoxicity through AMPK pathway. Neuroscience 2014; 278:31-9; PMID:25130556; http://dx.doi.org/10.1016/j.neuroscience.2014.07.072
31. C.Jo, S.Kim, S.J.Cho, K.J.Choi, S.M.Yun, Y.H.Koh, G.V.Johnson, S.I.Park. Sulforaphane induces autophagy through ERK activation in neuronal cells. FEBS Lett 2014; 588:3081-8; PMID:24952354; http://dx.doi.org/10.1016/j.febslet.2014.06.036
32. D.Terwel, D.Muyllaert, I.Dewachter, P.Borghgraef, S.Croes, H.Devijver, F.Van Leuven. Amyloid activates GSK-3beta to aggravate neuronal tauopathy in bigenic mice. Am J Pathol 2008; 172:786-98; PMID:18258852; http://dx.doi.org/10.2353/ajpath.2008.070904
33. G.Joshi, K.A.Gan, D.A.Johnson, J.A.Johnson. Increased Alzheimer's disease-like pathology in the APP/ PS1DeltaE9 mouse model lacking Nrf2 through modulation of autophagy. Neurobiol Aging 2015; 36:664-79; PMID:25316599; http://dx.doi.org/10.1016/j.neurobiolaging.2014.09.004
34. A.D.Kraft, J.M.Lee, D.A.Johnson, Y.W.Kan, J.A.Johnson. Neuronal sensitivity to kainic acid is dependent on the Nrf2-mediated actions of the antioxidant response element. J Neurochem 2006; 98:1852-65; PMID:16945104; http://dx.doi.org/10.1111/j.1471-4159.2006.04019.x
35. M.Dodson, M.Redmann, N.S.Rajasekaran, V.Darley-Usmar, J.Zhang. KEAP1-NRF2 signalling and autophagy in protection against oxidative and reductive proteotoxicity. Biochem J 2015; 469:347-55; PMID:26205490; http://dx.doi.org/10.1042/BJ20150568
36. C.Settembre, A.Ballabio. TFEB regulates autophagy:an integrated coordination of cellular degradation and recycling processes. Autophagy 2011; 7:1379-81; PMID:21785263; http://dx.doi.org/10.4161/auto.7.11.17166
37. J.Fullgrabe, D.J.Klionsky, B.Joseph. Histone post-translational modifications regulate autophagy flux and outcome. Autophagy 2013; 9:1621-3; PMID:23934085; http://dx.doi.org/10.4161/auto.25803
38. A.Lau, W.Tian, S.A.Whitman, D.D.Zhang. The predicted molecular weight of Nrf2:it is what it is not. Antioxid Redox Signal 2013; 18:91-3; PMID:22703241; http://dx.doi.org/10.1089/ars.2012.4754
39. K.Itoh, K.Igarashi, N.Hayashi, M.Nishizawa, M.Yamamoto. Cloning and characterization of a novel erythroid cell-derived CNC family transcription factor heterodimerizing with the small Maf family proteins. Mol Cell Biol 1995; 15:4184-93; PMID:7623813; http://dx.doi.org/10.1128/MCB.15.8.4184
40. K.Igarashi, H.Hoshino, A.Muto, N.Suwabe, S.Nishikawa, H.Nakauchi, M.Yamamoto. Multivalent DNA binding complex generated by small Maf and Bach1 as a possible biochemical basis for beta-globin locus control region complex. J Biol Chem 1998; 273:11783-90; PMID:9565602; http://dx.doi.org/10.1074/jbc.273.19.11783
41. D.D.Zhang. Mechanistic studies of the Nrf2-Keap1 signaling pathway. Drug Metab Rev 2006; 38:769-89; PMID:17145701; http://dx.doi.org/10.1080/03602530600971974
42. D.D.Zhang, S.C.Lo, J.V.Cross, D.J.Templeton, M.Hannink. Keap1 is a redox-regulated substrate adaptor protein for a Cul3-dependent ubiquitin ligase complex. Mol Cell Biol 2004; 24:10941-53; PMID:15572695; http://dx.doi.org/10.1128/MCB.24.24.10941-10953.2004
43. D.C.Rubinsztein, P.Codogno, B.Levine. Autophagy modulation as a potential therapeutic target for diverse diseases. Nat Rev Drug Dis 2012; 11:709-30; PMID:22935804; http://dx.doi.org/10.1038/nrd3802
44. P.Nilsson, K.Loganathan, M.Sekiguchi, Y.Matsuba, K.Hui, S.Tsubuki, M.Tanaka, N.Iwata, T.Saito, T.C.Saido. Abeta secretion and plaque formation depend on autophagy. Cell Rep 2013; 5:61-9; PMID:24095740; http://dx.doi.org/10.1016/j.celrep.2013.08.042
45. L.Agholme, M.Hallbeck, E.Benedikz, J.Marcusson, K.Kagedal. Amyloid-beta secretion, generation, and lysosomal sequestration in response to proteasome inhibition:involvement of autophagy. J Alzheimer's Dis 2012; 31:343-58; PMID:22555375
46. S.M.Son, H.Song, J.Byun, K.S.Park, H.C.Jang, Y.J.Park, I.Mook-Jung. Accumulation of autophagosomes contributes to enhanced amyloidogenic APP processing under insulin-resistant conditions. Autophagy 2012; 8:1842-4; PMID:22931791; http://dx.doi.org/10.4161/auto.21861
47. L.Zheng, A.Terman, M.Hallbeck, N.Dehvari, R.F.Cowburn, E.Benedikz, K.Kågedal, A.Cedazo-Minguez, J.Marcusson. Macroautophagy-generated increase of lysosomal amyloid beta-protein mediates oxidant-induced apoptosis of cultured neuroblastoma cells. Autophagy 2011; 7:1528-45; PMID:22108004; http://dx.doi.org/10.4161/auto.7.12.18051
48. W.H.Yu, A.M.Cuervo, A.Kumar, C.M.Peterhoff, S.D.Schmidt, J.H.Lee, P.S.Mohan, M.Mercken, M.R.Farmery, L.O.Tjernberg, et al. Macroautophagy–a novel Beta-amyloid peptide-generating pathway activated in Alzheimer's disease. J Cell Biol 2005; 171:87-98; PMID:16203860; http://dx.doi.org/10.1083/jcb.200505082
49. W.H.Yu, A.Kumar, C.Peterhoff, L.Shapiro Kulnane, Y.Uchiyama, B.T.Lamb, A.M.Cuervo, R.A.Nixon. Autophagic vacuoles are enriched in amyloid precursor protein-secretase activities:implications for beta-amyloid peptide over-production and localization in Alzheimer's disease. Int J Biochem Cell Biol 2004; 36:2531-40; PMID:15325590; http://dx.doi.org/10.1016/j.biocel.2004.05.010
50. S.H.Pasternak, R.D.Bagshaw, M.Guiral, S.Zhang, C.A.Ackerley, B.J.Pak, J.W.Callahan, D.J.Mahuran. Presenilin-1, nicastrin, amyloid precursor protein, and gamma-secretase activity are co-localized in the lysosomal membrane. J Biol Chem 2003; 278:26687-94; PMID:12736250; http://dx.doi.org/10.1074/jbc.M304009200
51. P.Nilsson, M.Sekiguchi, T.Akagi, S.Izumi, T.Komori, K.Hui, K.Sörgjerd, M.Tanaka, T.Saito, N.Iwata, et al. Autophagy-related protein 7 deficiency in amyloid beta (Abeta) precursor protein transgenic mice decreases Abeta in the multivesicular bodies and induces Abeta accumulation in the Golgi. Am J Pathol 2015; 185:305-13; PMID:25433221; http://dx.doi.org/10.1016/j.ajpath.2014.10.011
52. Y.Wang, E.Mandelkow. Degradation of tau protein by autophagy and proteasomal pathways. Biochemical Society transactions 2012; 40:644-52; PMID:22817709; http://dx.doi.org/10.1042/BST20120071
53. A.Caccamo, A.Magri, D.X.Medina, E.V.Wisely, M.F.Lopez-Aranda, A.J.Silva, S.Oddo. mTOR regulates tau phosphorylation and degradation:implications for Alzheimer's disease and other tauopathies. Aging cell 2013; 12:370-80; PMID:23425014; http://dx.doi.org/10.1111/acel.12057
54. Y.Liu, Y.Su, J.Wang, S.Sun, T.Wang, X.Qiao, X.Run, H.Li, Z.Liang. Rapamycin decreases tau phosphorylation at Ser214 through regulation of cAMP-dependent kinase. Neurochem Int 2013; 62:458-67; PMID:23357480; http://dx.doi.org/10.1016/j.neuint.2013.01.014
55. S.Ozcelik, G.Fraser, P.Castets, V.Schaeffer, Z.Skachokova, K.Breu, F.Clavaguera, M.Sinnreich, L.Kappos, M.Goedert, et al. Rapamycin attenuates the progression of tau pathology in P301S tau transgenic mice. PloS one 2013; 8:e62459; PMID:23667480; http://dx.doi.org/10.1371/journal.pone.0062459
56. D.C.Rubinsztein, M.DiFiglia, N.Heintz, R.A.Nixon, Z.H.Qin, B.Ravikumar, L.Stefanis, A.Tolkovsky. Autophagy and its possible roles in nervous system diseases, damage and repair. Autophagy 2005; 1:11-22; PMID:16874045; http://dx.doi.org/10.4161/auto.1.1.1513
57. M.Martinez-Vicente. Autophagy in neurodegenerative diseases:From pathogenic dysfunction to therapeutic modulation. Semin Cell Dev Biol 2015; 40:115-26; PMID:25843774; http://dx.doi.org/10.1016/j.semcdb.2015.03.005
58. Y.C.Wong, E.L.Holzbaur. Autophagosome dynamics in neurodegeneration at a glance. J Cell Sci 2015; 128:1259-67; PMID:25829512; http://dx.doi.org/10.1242/jcs.161216
59. E.J.Goetzl, A.Boxer, J.B.Schwartz, E.L.Abner, R.C.Petersen, B.L.Miller, D.Kapogiannis. Altered lysosomal proteins in neural-derived plasma exosomes in preclinical Alzheimer disease. Neurology 2015; 85:40-7; PMID:26062630; http://dx.doi.org/10.1212/WNL.0000000000001702
60. C.P.Ramsey, C.A.Glass, M.B.Montgomery, K.A.Lindl, G.P.Ritson, L.A.Chia, R.L.Hamilton, C.T.Chu, K.L.Jordan-Sciutto. Expression of Nrf2 in neurodegenerative diseases. J Neuropathol Exp Neurol 2007; 66:75-85; PMID:17204939; http://dx.doi.org/10.1097/nen.0b013e31802d6da9
61. A.K.Raina, D.J.Templeton, J.C.Deak, G.Perry, M.A.Smith. Quinone reductase (NQO1), a sensitive redox indicator, is increased in Alzheimer's disease. Redox Rep 1999; 4:23-7; PMID:10714272; http://dx.doi.org/10.1179/135100099101534701
62. Y.Wang, K.Santa-Cruz, C.DeCarli, J.A.Johnson. NAD(P)H:quinone oxidoreductase activity is increased in hippocampal pyramidal neurons of patients with Aalzheimer's disease. Neurobiol Aging 2000; 21:525-31; PMID:10924765; http://dx.doi.org/10.1016/S0197-4580(00)00114-7
63. H.M.Schipper, D.A.Bennett, A.Liberman, J.L.Bienias, J.A.Schneider, J.Kelly, Z.Arvanitakis. Glial heme oxygenase-1 expression in Alzheimer disease and mild cognitive impairment. Neurobiol Aging 2006; 27:252-61; PMID:16399210; http://dx.doi.org/10.1016/j.neurobiolaging.2005.01.016
64. K.Tanji, Y.Miki, T.Ozaki, A.Maruyama, H.Yoshida, J.Mimura, T.Matsumiya, F.Mori, T.Imaizumi, K.Itoh, et al. Phosphorylation of serine 349 of p62 in Alzheimer's disease brain. Acta neuropathologica communications 2014; 2:50; PMID:24886973; http://dx.doi.org/10.1186/2051-5960-2-50
65. N.C.Inestrosa, A.E.Reyes, M.A.Chacon, W.Cerpa, A.Villalon, J.Montiel, G.Merabachvili, R.Aldunate, F.Bozinovic, F.Aboitiz. Human-like rodent amyloid-beta-peptide determines Alzheimer pathology in aged wild-type Octodon degu. Neurobiol Aging 2005; 26:1023-8; PMID:15748782; http://dx.doi.org/10.1016/j.neurobiolaging.2004.09.016
66. M.von Otter, S.Landgren, S.Nilsson, M.Zetterberg, D.Celojevic, P.Bergstrom, L.Minthon, N.Bogdanovic, N.Andreasen, D.R.Gustafson, et al. Nrf2-encoding NFE2L2 haplotypes influence disease progression but not risk in Alzheimer's disease and age-related cataract. Mechanisms Ageing Dev 2010; 131:105-10; PMID:20064547; http://dx.doi.org/10.1016/j.mad.2009.12.007
67. M.von Otter, P.Bergstrom, A.Quattrone, E.V.De Marco, G.Annesi, P.Soderkvist, S.B.Wettinger, M.Drozdzik, M.Bialecka, H.Nissbrandt, et al. Genetic associations of Nrf2-encoding NFE2L2 variants with Parkinson's disease - a multicenter study. BMC Med Genet 2014; 15:131; PMID:25496089; http://dx.doi.org/10.1186/s12881-014-0131-4
68. P.Bergstrom, M.von Otter, S.Nilsson, A.C.Nilsson, M.Nilsson, P.M.Andersen, O.Hammarsten, H.Zetterberg. Association of NFE2L2 and KEAP1 haplotypes with amyotrophic lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener 2014; 15:130-7; PMID:24102512; http://dx.doi.org/10.3109/21678421.2013.839708
69. L.Gan, M.R.Vargas, D.A.Johnson, J.A.Johnson. Astrocyte-specific overexpression of Nrf2 delays motor pathology and synuclein aggregation throughout the CNS in the alpha-synuclein mutant (A53T) mouse model. J Neurosci 2012; 32:17775-87; PMID:23223297; http://dx.doi.org/10.1523/JNEUROSCI.3049-12.2012
70. I.Lastres Becker, A.J.Garcia-Yague, R.H.Scannevin, M.J.Casarejos, S.Kugler, A.Rabano, et al. Repurposing the NRF2 activator dimethyl fumarate as therapy against synucleinopathy in Parkinson's disease. Antioxid Redox Signal 2016; 25(2):61-77
71. L.C.Bott, N.M.Badders, K.L.Chen, G.G.Harmison, E.Bautista, C.C.Shih, M.Katsuno, G.Sobue, J.P.Taylor, N.P.Dantuma, et al. A small-molecule Nrf1 and Nrf2 activator mitigates polyglutamine toxicity in spinal and bulbar muscular atrophy. Hum Mol Genet 2016; PMID:26962150; http://dx.doi.org/10.1093/hmg/ddw073
72. D.Terwel, R.Lasrado, J.Snauwaert, E.Vandeweert, C.Van Haesendonck, P.Borghgraef, F.Van Leuven. Changed conformation of mutant Tau-P301L underlies the moribund tauopathy, absent in progressive, nonlethal axonopathy of Tau-4R/2N transgenic mice. J Biol Chem 2005; 280:3963-73; PMID:15509565; http://dx.doi.org/10.1074/jbc.M409876200
73. D.Moechars, I.Dewachter, K.Lorent, D.Reverse, V.Baekelandt, A.Naidu, I.Tesseur, K.Spittaels, C.V.Haute, F.Checler, et al. Early phenotypic changes in transgenic mice that overexpress different mutants of amyloid precursor protein in brain. J Biol Chem 1999; 274:6483-92; PMID:10037741; http://dx.doi.org/10.1074/jbc.274.10.6483
74. I.Lastres-Becker, N.G.Innamorato, T.Jaworski, A.Rabano, S.Kugler, F.Van Leuven, A.Cuadrado. Fractalkine activates NRF2/NFE2L2 and heme oxygenase 1 to restrain tauopathy-induced microgliosis. Brain 2014; 137:78-91; PMID:24277722; http://dx.doi.org/10.1093/brain/awt323
75. A.I.Rojo, O.N.Medina-Campos, P.Rada, A.Zuniga-Toala, A.Lopez-Gazcon, S.Espada, J.Pedraza-Chaverri, A.Cuadrado. Signaling pathways activated by the phytochemical nordihydroguaiaretic acid contribute to a Keap1-independent regulation of Nrf2 stability:Role of glycogen synthase kinase-3. Free Radic Biol Med 2012; 52:473-87; PMID:22142471; http://dx.doi.org/10.1016/j.freeradbiomed.2011.11.003
76. A.I.Rojo, N.G.Innamorato, A.M.Martin-Moreno, M.L.De Ceballos, M.Yamamoto, A.Cuadrado. Nrf2 regulates microglial dynamics and neuroinflammation in experimental Parkinson's disease. Glia 2010; 58:588-98; PMID:19908287; http://dx.doi.org/10.1002/glia.20947